Clinical Usefulness of a Cell-based Assay for Detecting Myelin Oligodendrocyte Glycoprotein Antibodies in Central Nervous System Inflammatory Disorders.
Jin Myoung SeokPatrick J WatersMi Young JeonHye Lim LeeSeol-Hee BaekJin-Sung ParkSa-Yoon KangOhyun KwonJeeyoung OhByung-Jo KimKyung-Ah ParkSei Yeul OhByoung Joon KimJu-Hong MinPublished in: Annals of laboratory medicine (2023)
The in-house CBA for MOG-Abs demonstrated reliable results and can potentially be used to evaluate CNS inflammatory disorders. A comprehensive, long-term study with a large patient population would clarify the clinical significance of MOG-Abs.